The import of bulk drugs and drug intermediates from China stood at USD 2,055.94 million in 2017-18, accounting for 68.68 percent of their total import, Minister of Chemicals and Fertilizers D V Sadananda Gowda said in a reply to the Lok Sabha.
The industry has also sought the government's intervention for faster clearances of their drug applications, quicker response of remedial actions after USFDA's warning letters and faster resumption of drug supplies
Washington: A US class action lawsuit accusing India's Ranbaxy of large-scale deception on its generic drug applications puts a question mark on drug imports from India, the largest supplier of generic drugs to the US.The
Top News
Latest News
